The DOI matches its Crossref record; 159 of the 159 references it cites were found in a registry or an index.
Role of central dopamine in pain and analgesia
Abstract
Recent insights have demonstrated a central role for dopaminergic neurotransmission in modulating pain perception and natural analgesia within supraspinal regions, including the basal ganglia, insula, anterior cingulate cortex, thalamus and periaqueductal gray. In addition, while the participation of serotonin and norepinephrine in spinal descending inhibition of pain is well known, a critical role for dopamine in descending inhibition has also been demonstrated. Decreased levels of dopamine likely contribute to the painful symptoms that frequently occur in Parkinson's disease. Moreover, abnormalities in dopaminergic neurotransmission have been objectively demonstrated in painful clinical conditions, including burning mouth syndrome, fibromyalgia and restless legs syndrome. Evidence from animal models and indirect evidence from pharmaceutical trials also suggest a role for dopamine in chronic regional pain syndrome and painful diabetic neuropathy. Several novel classes of medication with analgesic properties have bearing on dopaminergic activity as evident in the capacity of dopamine antagonists to attenuate their analgesic capacity. An expanded appreciation for the role of dopamine in natural analgesia provides the impetus for further study involving preclinical models and advanced neuroimaging techniques in humans, which may lead to the development of novel therapeutic strategies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Functional imaging of brain responses to pain. A review and meta-analysis (2000)
Peyron, R., Laurent, B., & García-Larrea, L. (2000) · Neurophysiologie Clinique/Clinical Neurophysiology · doi:10.1016/s0987-7053(00)00227-6 · Cited by 2,171
Swanson, L. W., & Kuypers, H. G. J. M. (1980) · Journal of Comparative Neurology · doi:10.1002/cne.901940306 · Cited by 1,413
Functional magnetic resonance imaging evidence of augmented pain processing in fibromyalgia
Gracely, R. H., Petzke, F., Wolf, J. M., & Clauw, D. J. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10225 · Cited by 1,263
Männistö, P. T., & Kaakkola, S. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01423-6 · Cited by 1,068
An internet survey of 2,596 people with fibromyalgia
Bennett, R. M., Jones, J., Turk, D. C., Russell, I. J., & Matallana, L. (2007) · BMC Musculoskeletal Disorders · doi:10.1186/1471-2474-8-27 · Cited by 865
Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis
Rog, D. J., Nurmikko, T. J., Friede, T., & Young, C. A. (2005) · Neurology · doi:10.1212/01.wnl.0000176753.45410.8b · Cited by 679
Johansen, J. P., Fields, H. L., & Manning, B. H. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.141218998 · Cited by 676
Cortical Representation of the Sensory Dimension of Pain
Hofbauer, R. K., Rainville, P., Duncan, G. H., & Bushnell, M. C. (2001) · Journal of Neurophysiology · doi:10.1152/jn.2001.86.1.402 · Cited by 611
The role of the basal ganglia in nociception and pain
Chudler, E. H., & Dong, W. K. (1995) · Pain · doi:10.1016/0304-3959(94)00172-b · Cited by 599
Dissociation of sensory and affective dimensions of pain using hypnotic modulation.
Rainville, P., Carrier, B., Hofbauer, R. K., Bushnell, C. M., & Duncan, G. H. (1999) · Pain · doi:10.1016/s0304-3959(99)00048-2 · Cited by 530
A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain
Wernicke, J. F., Pritchett, Y. L., D’Souza, D. N., Waninger, A., Tran, P., Iyengar, S., & Raskin, J. (2006) · Neurology · doi:10.1212/01.wnl.0000240225.04000.1a · Cited by 510
Champtiaux, N., Gotti, C., Cordero-Erausquin, M., David, D. J., Przybylski, C., Léna, C., Clementi, F., Moretti, M., Rossi, F. M., Le Novère, N., et al. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-21-07820.2003 · Cited by 507
Arnold, L. M., Rosen, A., Pritchett, Y. L., D'Souza, D. N., Goldstein, D. J., Iyengar, S., & Wernicke, J. F. (2005) · Pain · doi:10.1016/j.pain.2005.06.031 · Cited by 471
Individual differences in reward responding explain placebo-induced expectations and effects
Scott, D. J., Stohler, C. S., Egnatuk, C. M., Wang, H., Koeppe, R. A., & Zubieta, J.-K. (2007) · Neuron · doi:10.1016/j.neuron.2007.06.028 · Cited by 466
Kapur, S., & Seeman, P. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001093 · Cited by 459
THE γ-HYDROXYBUTYRATE SIGNALLING SYSTEM IN BRAIN: ORGANIZATION AND FUNCTIONAL IMPLICATIONS
MAITRE, M. (1997) · Progress in Neurobiology · doi:10.1016/s0301-0082(96)00064-0 · Cited by 453
Glutamate, Dopamine, and Schizophrenia: From Pathophysiology to Treatment
LARUELLE, M., KEGELES, L. S., & ABI‐DARGHAM, A. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1300.063 · Cited by 437
Grace, A. A. (2000) · Addiction · doi:10.1046/j.1360-0443.95.8s2.1.x · Cited by 433
Salamone, J. D., Correa, M., Mingote, S., & Weber, S. M. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.035063 · Cited by 433
Gurevich, E. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00066-9 · Cited by 431
Fibromyalgia patients show an abnormal dopamine response to pain
Wood, P. B., Schweinhardt, P., Jaeger, E., Dagher, A., Hakyemez, H., Rabiner, E. A., Bushnell, M. C., & Chizh, B. A. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05623.x · Cited by 406
Self-citationTseng, K. Y., & O'Donnell, P. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.1021-04.2004 · Cited by 402
Functional imaging of pain in patients with primary fibromyalgia.
Cook, D. B., Lange, G., Ciccone, D. S., Liu, W., Steffener, J., & Natelson, B. H. (2004) · PubMed · Cited by 396
Nabilone for the treatment of pain in fibromyalgia.
Skrabek, R. Q., Galimova, L., Ethans, K., & Perry, D. (2008) · The Journal of Pain · doi:10.1016/j.jpain.2007.09.002 · Cited by 384
Gurden, H., Takita, M., & Jay, T. M. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-22-j0003.2000 · Cited by 366
Brefel‐Courbon, C., Payoux, P., Thalamas, C., Ory, F., Quelven, I., Chollet, F., Montastruc, J. L., & Rascol, O. (2005) · Movement Disorders · doi:10.1002/mds.20629 · Cited by 364
Morphine reward in dopamine-deficient mice
Hnasko, T. S., Sotak, B. N., & Palmiter, R. D. (2005) · Nature · doi:10.1038/nature04172 · Cited by 338
Autoradiographic localization of D1 dopamine receptors in the rat brain with [3H]SCH 23390
Savasta, M., Dubois, A., & Scatton, B. (1986) · Brain Research · doi:10.1016/0006-8993(86)90749-3 · Cited by 318
Scott, D. J., Heitzeg, M. M., Koeppe, R. A., Stohler, C. S., & Zubieta, J.-K. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.2577-06.2006 · Cited by 297
Quantitative measurement of pain sensation in patients with Parkinson disease
Djaldetti, R., Shifrin, A., Rogowski, Z., Sprecher, E., Melamed, E., & Yarnitsky, D. (2004) · Neurology · doi:10.1212/01.wnl.0000130455.38550.9d · Cited by 290
Holman, A. J., & Myers, R. R. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21191 · Cited by 289
Cannabis for dyskinesia in Parkinson disease: A randomized double-blind crossover study
Carroll, C. B., Bain, P. G., Teare, L., Liu, X., Joint, C., Wroath, C., Parkin, S. G., Fox, P., Wright, D., Hobart, J., et al. (2004) · Neurology · doi:10.1212/01.wnl.0000140288.48796.8e · Cited by 286
The role of dopamine in the nucleus accumbens in analgesia
Altier, N., & Stewart, J. (1999) · Life Sciences · doi:10.1016/s0024-3205(99)00298-2 · Cited by 273
Correll, G. E., Maleki, J., Gracely, E. J., Muir, J. J., & Harbut, R. E. (2004) · Pain Medicine · doi:10.1111/j.1526-4637.2004.04043.x · Cited by 271
Yavich, L., Forsberg, M. M., Karayiorgou, M., Gogos, J. A., & Männistö, P. T. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.0665-07.2007 · Cited by 269
Striatal dopamine D1 and D2 receptors in burning mouth syndrome
Hagelberg, N., Forssell, H., Rinne, J. O., Scheinin, H., Taiminen, T., Aalto, S., Luutonen, S., Någren, K., & Jääskeläinen, S. (2003) · Pain · doi:10.1016/s0304-3959(02)00323-8 · Cited by 264
Role of the dopaminergic system in chronic pain – a fluorodopa-PET study
Jääskeläinen, S. K., Rinne, J. O., Forssell, H., Tenovuo, O., Kaasinen, V., Sonninen, P., & Bergman, J. (2001) · Pain · doi:10.1016/s0304-3959(00)00409-7 · Cited by 259
Double-blind, randomized trial of bupropion SR for the treatment of neuropathic pain
Semenchuk, M. R., Sherman, S., & Davis, B. (2001) · Neurology · doi:10.1212/wnl.57.9.1583 · Cited by 256
Molecular neurobiology of dopaminergic receptors
Sibley, D. R., Monsma, F. J., & Shen, Y. (1993) · International review of neurobiology · doi:10.1016/s0074-7742(08)60573-5 · Cited by 255
The organization and function of endogenous antinociceptive systems
Sandkühler, J. (1996) · Progress in Neurobiology · doi:10.1016/0301-0082(96)00031-7 · Cited by 255
Sang, C. N., Booher, S., Gilron, I., Parada, S., & Max, M. B. (2002) · Anesthesiology · doi:10.1097/00000542-200205000-00005 · Cited by 254
Wallace, M., Schulteis, G., Atkinson, J. H., Wolfson, T., Lazzaretto, D., Bentley, H., Gouaux, B., & Abramson, I. (2007) · Anesthesiology · doi:10.1097/01.anes.0000286986.92475.b7 · Cited by 252
Support for dopaminergic hypoactivity in restless legs syndrome: a PET study on D2-receptor binding
Cervenka, S. (2006) · Brain · doi:10.1093/brain/awl163 · Cited by 252
Wood, P. B., Patterson, J. C., Sunderland, J. J., Tainter, K. H., Glabus, M. F., & Lilien, D. L. (2007) · The Journal of Pain · doi:10.1016/j.jpain.2006.05.014 · Cited by 245
Self-citationJasmin, L., Granato, A., & Ohara, P. T. (2004) · Journal of Comparative Neurology · doi:10.1002/cne.10978 · Cited by 237
Dopamine D5 receptors of rat and human brain
Khan, Z. U., Gutiérrez, A., Martı́n, R., Peñafiel, A., Rivera, A., & de la Calle, A. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00274-8 · Cited by 235
D3 dopamine receptor mRNA is widely expressed in the human brain
Suzuki, M., Hurd, Y. L., Sokoloff, P., Schwartz, J.-C., & Sedvall, G. (1998) · Brain Research · doi:10.1016/s0006-8993(97)01078-0 · Cited by 232
Neurotensin: Antinocisponsive action in rodents
Clineschmidt, B. V., McGuffin, J. C., & Bunting, P. B. (1979) · European Journal of Pharmacology · doi:10.1016/0014-2999(79)90415-1 · Cited by 229
Pain and motor complications in Parkinson's disease
Tinazzi, M. (2006) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2005.079053 · Cited by 228
Kotecha, S. A., Oak, J. N., Jackson, M. F., Perez, Y., Orser, B. A., Van Tol, H. H. M., & MacDonald, J. F. (2002) · Neuron · doi:10.1016/s0896-6273(02)00859-0 · Cited by 227
Neurophysiologic study of central pain in patients with Parkinson disease
Schestatsky, P., Kumru, H., Valls-Solé, J., Valldeoriola, F., Marti, M. J., Tolosa, E., & Chaves, M. L. (2007) · Neurology · doi:10.1212/01.wnl.0000295669.12443.d3 · Cited by 226
Levodopa raises objective pain threshold in Parkinson's disease: a RIII reflex study
Gerdelat-Mas, A., Simonetta-Moreau, M., Thalamas, C., Ory-Magne, F., Slaoui, T., Rascol, O., & Brefel-Courbon, C. (2007) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2007.120212 · Cited by 223
Magnusson, J. E., & Fisher, K. (2000) · Brain Research · doi:10.1016/s0006-8993(99)02396-3 · Cited by 222
Dopamine D5 receptor immunolocalization in rat and monkey brain
Ciliax, B. J., Nash, N., Heilman, C., Sunahara, R., Hartney, A., Tiberi, M., Rye, D. B., Caron, M. G., Niznik, H. B., & Levey, A. I. (2000) · Synapse · doi:10.1002/1098-2396(200008)37:2<125::aid-syn7>3.0.co;2-7 · Cited by 210
Gresch, P. J., Sved, A. F., Zigmond, M. J., & Finlay, J. M. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.65010111.x · Cited by 208
The role of neurotensin in central nervous system pathophysiology: What is the evidence?
St-Gelais, F., Jomphe, C., & Trudeau, L.-É. (2006) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0627 · Cited by 207
Altered dopamine D2 receptor binding in atypical facial pain
Hagelberg, N., Forssell, H., Aalto, S., Rinne, J. O., Scheinin, H., Taiminen, T., Någren, K., Eskola, O., & Jääskeläinen, S. K. (2003) · Pain · doi:10.1016/s0304-3959(03)00275-6 · Cited by 205
Willert, R. P., Woolf, C. J., Hobson, A. R., Delaney, C., Thompson, D. G., & Aziz, Q. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.11.047 · Cited by 202
Dopamine receptor contribution to the action of PCP, LSD and ketamine psychotomimetics
Seeman, P., Ko, F., & Tallerico, T. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001682 · Cited by 200
A Survey of Pain in Idiopathic Parkinson's Disease
Lee, M. A., Walker, R. W., Hildreth, T. J., & Prentice, W. M. (2006) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2006.05.020 · Cited by 200
The effects of sodium oxybate on clinical symptoms and sleep patterns in patients with fibromyalgia.
Scharf, M. B., Baumann, M. M., & Berkowitz, D. V. (2003) · PubMed · Cited by 197
Jørum, E., Warncke, T., & Stubhaug, A. (2003) · Pain · doi:10.1016/s0304-3959(02)00122-7 · Cited by 196
Carr, D. B., Goudas, L. C., Denman, W. T., Brookoff, D., Staats, P. S., Brennen, L., Green, G., Albin, R., Hamilton, D., Rogers, M. C., et al. (2004) · Pain · doi:10.1016/j.pain.2003.07.001 · Cited by 189
Stiasny-Kolster, K. (2004) · Brain · doi:10.1093/brain/awh079 · Cited by 188
Survey on cannabis use in Parkinson's disease: Subjective improvement of motor symptoms
Venderová, K., Růžička, E., Voříšek, V., & Višňovský, P. (2004) · Movement Disorders · doi:10.1002/mds.20111 · Cited by 175
Clinical Pharmacokinetics of Ropinirole
Kaye, C. M., & Nicholls, B. (2000) · Clinical Pharmacokinetics · doi:10.2165/00003088-200039040-00001 · Cited by 175
Restless legs syndrome and leg cramps in fibromyalgia syndrome: a controlled study: Table 1
Yunus, M. B., & Aldag, J. C. (1996) · BMJ · doi:10.1136/bmj.312.7042.1339 · Cited by 170
Saadé, N. E., Atweh, S., Bahuth, N. B., & Jabbur, S. J. (1997) · Brain Research · doi:10.1016/s0006-8993(96)01164-x · Cited by 166
Dopamine Reuptake Inhibition in the Rostral Agranular Insular Cortex Produces Antinociception
Burkey, A. R., Carstens, E. E., & Jasmin, L. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-10-04169.1999 · Cited by 164
Effect of gamma-hydroxybutyrate on dopamine and dopamine metabolites in the rat striatum
Walters, J. R., & Roth, R. H. (1972) · Biochemical Pharmacology · doi:10.1016/0006-2952(72)90164-5 · Cited by 163
Distribution of dopamine immunoreactivity in the rat, cat, and monkey spinal cord
Holstege, J. C., van Dijken, H., Buijs, R. M., Goedknegt, H., Gosens, T., & Bongers, C. M. H. (1996) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19961223)376:4<631::aid-cne10>3.0.co;2-p · Cited by 163
Stress and dopamine: implications for the pathophysiology of chronic widespread pain
Wood, P. B. (2004) · Medical Hypotheses · doi:10.1016/j.mehy.2003.10.013 · Cited by 163
Self-citation(2012) · Parkinson's Disease · doi:10.1201/b12948-20 · Cited by 163
Stimulation of dopamine D2 receptors in the nucleus accumbens inhibits inflammatory pain
Taylor, B. K., Joshi, C., & Uppal, H. (2003) · Brain Research · doi:10.1016/s0006-8993(03)03318-3 · Cited by 161
Hagelberg, N. M., Martikainen, I. K., Mansikka, H. T., Hinkka‐Yli‐Salomäki, S., Någren, K., Hietala, J. A., Scheinin, H., & Pertovaara, A. (2002) · Pain · doi:10.1016/s0304-3959(02)00121-5 · Cited by 152
Antidepressant-like actions of DOV 21,947: a “triple” reuptake inhibitor
Skolnick, P., Popik, P., Janowsky, A. J., Beer, B., & LIPPA, A. S. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01310-4 · Cited by 148
Marinelli, S., Pascucci, T., Bernardi, G., Puglisi‐Allegra, S., & Mercuri, N. B. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300615 · Cited by 145
Flores, J. A., Banoua, F. E., Galán-Rodríguez, B., & Fernández‐Espejo, E. (2004) · Pain · doi:10.1016/j.pain.2004.03.036 · Cited by 145
Aimone, L. D., Jones, S. L., & Gebhart, G. F. (1987) · Pain · doi:10.1016/0304-3959(87)90012-1 · Cited by 138
Jensen, T. S., & Yaksh, T. L. (1984) · Brain Research · doi:10.1016/0006-8993(84)90064-7 · Cited by 129
Comparative Efficacy of SSRIs and Amisulpride in Burning Mouth Syndrome
Maina, G., Vitalucci, A., GANDOLFO, S., & Bogetto, F. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n0108 · Cited by 126
Multi-Day Low Dose Ketamine Infusion for the Treatment of Complex Regional Pain Syndrome
Goldberg, M. E., Domsky, R., Scaringe, D., Hirsh, R., Dotson, J., Sharaf, I., Torjman, M. C., & Schwartzman Robert, J. (2005) · Pain Physician · doi:10.36076/ppj.2005/8/175 · Cited by 125
Kihara, T., & Ikeda, M. (1995) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24303-8 · Cited by 123
Kehl, L. J., Hamamoto, D. T., Wacnik, P. W., Croft, D. L., Norsted, B. D., Wilcox, G. L., & Simone, D. A. (2003) · Pain · doi:10.1016/s0304-3959(02)00450-5 · Cited by 121
Memantine agonist action at dopamine D2High receptors
Seeman, P. M., Caruso, C. M., & Lasaga, M. (2007) · Synapse · doi:10.1002/syn.20472 · Cited by 121
McKenna, J. E., & Melzack, R. (2001) · Experimental Neurology · doi:10.1006/exnr.2001.7777 · Cited by 120
Cannabinoid self-administration increases dopamine release in the nucleus accumbens
Fadda, P., Scherma, M., Spano, M. S., Salis, P., Melis, V., Fattore, L., & Fratta, W. (2006) · Neuroreport · doi:10.1097/01.wnr.0000236853.40221.8e · Cited by 118
Tamae, A., Nakatsuka, T., Koga, K., Kato, G., Furue, H., Katafuchi, T., & Yoshimura, M. (2005) · The Journal of Physiology · doi:10.1113/jphysiol.2005.091843 · Cited by 117
Dopaminergic input to GABAergic neurons in the rostral agranular insular cortex of the rat
Ohara, P. T., Granato, A., Moallem, T. M., Wang, B.-R., Tillet, Y., & Jasmin, L. (2003) · Journal of Neurocytology · doi:10.1023/b:neur.0000005598.09647.7f · Cited by 111
Potvin, S., & Marchand, S. (2007) · Pain · doi:10.1016/j.pain.2007.11.007 · Cited by 108
The Effect of Duloxetine on Primary Pain Symptoms in Parkinson Disease
Djaldetti, R., Yust‐Katz, S., Kolianov, V., Melamed, E., & Dabby, R. (2007) · Clinical Neuropharmacology · doi:10.1097/wnf.0b013e3180340319 · Cited by 107
D3 dopamine receptors in rat spinal cord: implications for sensory and motor function
Levant, B., & McCarson, K. E. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)01692-5 · Cited by 105
Dopamine and NMDA systems modulate long-term nociception in the rat anterior cingulate cortex
López-Ávila, A., Coffeen, U., Ortega-Legaspi, M. J., del Ángel, R., & Pellicer, F. (2004) · Pain · doi:10.1016/j.pain.2004.06.010 · Cited by 104
Pedersen, L. H., Nielsen, A. N., & Blackburn-Munro, G. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0120-6 · Cited by 103
Dopamine receptors in the anterior insular cortex modulate long‐term nociception in the rat
Coffeen, U., López-Ávila, A., Ortega‐Legaspi, J. M., del Ángel, R., López‐Muñoz, F. J., & Pellicer, F. (2007) · European Journal of Pain · doi:10.1016/j.ejpain.2007.08.008 · Cited by 101
Pastoriza, L. N., Morrow, T., & Casey, K. L. (1996) · Pain · doi:10.1016/0304-3959(95)00070-4 · Cited by 98
Smith, J. W., Mogg, A. J., Tafi, E., Peacey, E., Pullar, I. A., Szekeres, P. G., & Tricklebank, M. D. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0596-8 · Cited by 97
Highly potent neurotensin analog that causes hypothermia and antinociception
Tyler-McMahon, B. M., Stewart, J. A., Fariñas, F., McCormick, D., & Richelson, E. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00877-8 · Cited by 86
Striatal dopamine D2 receptors attenuate neuropathic hypersensitivity in the rat
Ansah, O. B., Leite‐Almeida, H., Wei, H., & Pertovaara, A. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.03.010 · Cited by 86
NMDA receptors in the anterior cingulate cortex mediate pain-related aversion
LEI, L., Sun, S., Gao, Y., Zhao, Z., & Zhang, Y. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2004.06.012 · Cited by 86
Sotres-Bayón, F., Torres‐López, E., López-Ávila, A., del Ángel, R., & Pellicer, F. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02213-2 · Cited by 85
D2 dopamine receptor involvement in spinal dopamine-produced antinociception
Liu, Q.-S., Qiao, J., & Dafny, N. (1992) · Life Sciences · doi:10.1016/0024-3205(92)90558-7 · Cited by 84
Restless legs syndrome: Treatment with dopaminergic agents
Comella, C. L. (2002) · Neurology · doi:10.1212/wnl.58.suppl_1.s87 · Cited by 83
The effect of local and systemic application of dopaminergic agents on tail flick latency in the rat
Barasi, S., & Duggal, K. N. (1985) · European Journal of Pharmacology · doi:10.1016/0014-2999(85)90001-9 · Cited by 81
Cocaine: evidence for supraspinal, dopamine-mediated, non-opiate analgesia
Lin, Y., Morrow, T., Kiritsy‐Roy, J. A., Terry, L. C., & Casey, K. L. (1989) · Brain Research · doi:10.1016/0006-8993(89)91633-8 · Cited by 81
Talvik, M., Nordström, A., Okubo, Y., Olsson, H., Borg, J., Halldin, C., & Farde, L. (2006) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2006.05.009 · Cited by 80
Understanding the Placebo Effect: Contributions from Neuroimaging
Lidstone, S. C., & Stoessl, A. J. (2007) · Molecular Imaging and Biology · doi:10.1007/s11307-007-0086-3 · Cited by 80
Rosland, J. H., & Hole, K. (1990) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1990.tb06587.x · Cited by 77
A Randomized, Placebo-Controlled Trial of Bupropion Sustained Release in Chronic Low Back Pain
Katz, J., Pennella‐Vaughan, J., Hetzel, R. D., Kanazi, G. E., & Dworkin, R. H. (2005) · Journal of Pain · doi:10.1016/j.jpain.2005.05.002 · Cited by 76
Imaging Pain Modulation by Subanesthetic S-(+)-Ketamine
Sprenger, T., Valet, M., Woltmann, R., Zimmer, C., Freynhagen, R., Kochs, E. F., ̈lle, T. R. T., & Wagner, K. J. (2006) · Anesthesia & Analgesia · doi:10.1213/01.ane.0000231635.14872.40 · Cited by 75
Tang, L., Chen, Y., Chen, Z., Blumberg, P. M., Kozikowski, A. P., & Wang, Z. J. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.117572 · Cited by 75
Mb, S., Hauck, M., Stover, R., McDannold, M. D., & Berkowitz, D. (1998) · PubMed · Cited by 75
Are oral cannabinoids safe and effective in refractory neuropathic pain?
Attal, N., Brasseur, L., Guirimand, D., Clermond‐Gnamien, S., Atlami, S., & Bouhassira, D. (2004) · European Journal of Pain · doi:10.1016/s1090-3801(03)00084-3 · Cited by 74
The effects of racemic ketamine on painful stimulation of skin and viscera in human subjects
Strigo, I. A., Duncan, G. H., Bushnell, C. M., Boivin, M., Wainer, I. W., Rosas, E. M. R., & Persson, J. (2004) · Pain · doi:10.1016/j.pain.2004.10.023 · Cited by 74
Munro, G. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.07.062 · Cited by 73
Takeda, R., Ikeda, T., Tsuda, F., Abe, H., Hashiguchi, H., Ishida, Y., & Nishimori, T. (2005) · Neuroscience Research · doi:10.1016/j.neures.2005.01.005 · Cited by 71
Effects of dopaminergic agents on carrageenan hyperalgesia after intrathecal administration to rats
Gao, X. M., Zhang, Y., & Wu, G.-C. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)00930-x · Cited by 70
MAGNUSSO, O., Fowler, C. J., Köhler, C., & Ögren, S. O. (1986) · Neuropharmacology · doi:10.1016/0028-3908(86)90040-7 · Cited by 69
Memantine Treatment of Complex Regional Pain Syndrome: A Preliminary Report of Six Cases
Sinis, N., Birbaumer, N., Gustin, S. M., Schwarz, A., Bredanger, S., Becker, S. T., Unertl, K. E., Schaller, H., & Haerle, M. (2007) · Clinical Journal of Pain · doi:10.1097/ajp.0b013e31802f67a7 · Cited by 69
Schulte, H., Sollevi, A., & Segerdahl, M. (2004) · Anesthesia & Analgesia · doi:10.1213/01.ane.0000113237.89875.5d · Cited by 68
Direct inhibition of the N‐methyl‐ D ‐aspartate receptor channel by dopamine and (+)‐SKF38393
Castro, N. G., de Mello, M. C. F., Mello, F. G. D., & Aracava, Y. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702479 · Cited by 67
Martikainen, I. K., Hagelberg, N. M., Mansikka, H. T., Hietala, J. A., Någren, K., Scheinin, H., & Pertovaara, A. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.11.045 · Cited by 66
Varenicline: A Review of its Use as an Aid to Smoking Cessation Therapy
Keating, G. M., & Siddiqui, M. A. A. (2006) · CNS Drugs · doi:10.2165/00023210-200620110-00007 · Cited by 64
Fatty acid composition of the chronic subdural hematoma: with reference to its recurrence
Kubota, M., Narita, K., Nakagomi, T., Tamura, A., Hisaki, H., Shimasaki, H., & Ueta, N. (1998) · Journal of Clinical Neuroscience · doi:10.1016/s0967-5868(98)90204-1 · Cited by 63
Beazely, M. A., Tong, A., Wei, W., van Tol, H., Sidhu, B., & MacDonald, J. F. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04064.x · Cited by 63
Basile, A. S., Janowsky, A. J., Gołembiowska, K., Kowalska, M., Tam, E., Benveniste, M., Popik, P., Nikiforuk, A., Krawczyk, M., Nowak, G., et al. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.116483 · Cited by 62
Yang, H., Zhou, L., Hu, N., Xin, W., & Liu, X. (2005) · Journal of Neurophysiology · doi:10.1152/jn.01324.2004 · Cited by 60
Understanding the Placebo Effect: Contributions from Neuroimaging
Lidstone, S. C., & Stoessl, A. J. (2007) · Molecular Imaging and Biology · doi:10.1007/s11307-007-0098-z · Cited by 60
Madden, T., & Johnson, S. W. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37787-0 · Cited by 60
The NK1‐receptor antagonist TKA731 in painful diabetic neuropathy: A randomised, controlled trial
Sindrup, S. H., Graf, A., & Sfikas, N. (2005) · European Journal of Pain · doi:10.1016/j.ejpain.2005.08.001 · Cited by 59
Fantegrossi, W. E., Ko, M., Woods, J. H., & Richelson, E. (2004) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2004.12.005 · Cited by 58
Role of catecholamines and serotonin receptor subtypes in nefopam-induced antinociception
Girard, P., Coppé, M., Verniers, D., Pansart, Y., & Gillardin, J. M. (2006) · Pharmacological Research · doi:10.1016/j.phrs.2006.04.008 · Cited by 55
Antidepressant-like effects of novel triple reuptake inhibitors, PRC025 and PRC050
Shaw, A. M., Boules, M., Zhang, Y., Williams, K., Robinson, J. L. L., Carlier, P. R., & Richelson, E. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.10.004 · Cited by 53
Antinociceptive mechanism of l-DOPA
Shimizu, T., Iwata, S.-I., Morioka, H., Masuyama, T., Fukuda, T., & Nomoto, M. (2004) · Pain · doi:10.1016/j.pain.2004.03.038 · Cited by 53
Shyu, B., Kiritsy‐Roy, J. A., Morrow, T., & Casey, K. L. (1992) · Brain Research · doi:10.1016/0006-8993(92)90472-l · Cited by 50
Evidence of the involvement of dopamine in the analgesic effect of nefopam
Esposito, E., Romandini, S., Merlo‐Pich, E., Mennini, T., & SAMANIN, R. (1986) · European Journal of Pharmacology · doi:10.1016/0014-2999(86)90762-4 · Cited by 48
Amin, P., & Sturrock, N. D. C. (2003) · Diabetic Medicine · doi:10.1046/j.1464-5491.2003.00882.x · Cited by 44
The promise of N-methyl-d-aspartate receptor antagonists in fibromyalgia
Henriksson, K. G., & Sörensen, J. (2002) · Rheumatic Disease Clinics of North America · doi:10.1016/s0889-857x(01)00013-8 · Cited by 43
Stone, T. W. (1976) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1976.tb06964.x · Cited by 43
Modulators of nicotinic acetylcholine receptors as analgesics.
Jain, K. K. (2004) · PubMed · Cited by 42
An open-label study of quetiapine in the treatment of fibromyalgia
Hidalgo, J., Rico‐Villademoros, F., & Calandre, E. P. (2006) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2006.06.023 · Cited by 39
Freedenfeld, R. N., Murray, M., Fuchs, P. N., & Kiser, R. S. (2006) · Pain Practice · doi:10.1111/j.1533-2500.2006.00072.x · Cited by 38
Olanzapine for the Treatment of Fibromyalgia Symptoms
Kiser, R. S., Cohen, H. M., Freedenfeld, R. N., Jewell, C. E., & Fuchs, P. N. (2001) · Journal of Pain and Symptom Management · doi:10.1016/s0885-3924(01)00302-5 · Cited by 36
Multiple Dopamine Receptors in Brain and the Pharmacological Action of Substituted Benzamide Drugs
Jenner, P. G., & MARSDEN, C. D. (1984) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1984.tb06863.x · Cited by 36
D1 and NMDA receptors hook up: expanding on an emerging theme
Salter, M. W. (2003) · Trends in Neurosciences · doi:10.1016/s0166-2236(03)00081-x · Cited by 35
Amantadine Sulfate Reduces Experimental Sensitization and Pain in Chronic Back Pain Patients
hl, D. K., rtelmeyer, R. G., Bender, H., & lzl, R. H. (2006) · Anesthesia & Analgesia · doi:10.1213/01.ane.0000196691.82989.67 · Cited by 35
Moresco, R. M., Volonté, M., Messa, C., Gobbo, C., Galli, L., Carpinelli, A., Rizzo, G., Panzacchi, A., Franceschi, M., & Fazio, F. (2002) · Journal of Neural Transmission · doi:10.1007/s00702-002-0694-7 · Cited by 35
The antinociceptive effect of amisulpride in mice is mediated through opioid mechanisms
Weizman, T., Pick, C. G., Backer, M. M., et al. (2003) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2003.08.049 · Cited by 35
Is the dopaminergic system involved in the central effects of nicotine in mice?
Damaj, M. I., & Martin, B. R. (1993) · Psychopharmacology · doi:10.1007/bf02257415 · Cited by 33
Atypical antipsychotics in the treatment of fibromyalgia: a case series with olanzapine
Rico‐Villademoros, F., Hidalgo, J. L. L., Dominguez, I., Garcia‐Leiva, J. M., & Calandre, E. P. (2004) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2004.08.012 · Cited by 33
Wood, P. B. (2006) · Journal of Pain · doi:10.1016/j.jpain.2006.01.457 · Cited by 32
Self-citationInfluence of the dopamine D2 receptor knockout on pain-related behavior in the mouse
Mansikka, H. T., Erbs, E., Borrelli, E., & Pertovaara, A. (2005) · Brain Research · doi:10.1016/j.brainres.2005.06.021 · Cited by 31
Dopamine D2 receptor antagonists prevent Δ9-tetrahydrocannabinol-induced antinociception in rats
Carta, G., Gessa, G. L., & Nava, F. A. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00696-2 · Cited by 30
FORMAN, L. J. (1999) · Life Sciences · doi:10.1016/s0024-3205(99)00134-4 · Cited by 27
Ropinirole, Open Preliminary Observations of a Dopamine Agonist for Refractory Fibromyalgia
Holman, A. J. (2003) · JCR Journal of Clinical Rheumatology · doi:10.1097/01.rhu.0000081264.26484.e5 · Cited by 26
Use of ziprasidone in patients with fibromyalgia: a case series
Calandre, E. P., Hidalgo, J., & Rico‐Villademoros, F. (2006) · Rheumatology International · doi:10.1007/s00296-006-0243-z · Cited by 25
Holman, A. J., Neiman, R. A., & Ettlinger, R. E. (2004) · Journal of Musculoskeletal Pain · doi:10.1300/j094v12n01_10 · Cited by 20
Characterization of the analgesic properties of nomifensine in rats
Gilbert, A.-K., & Franklin, K. B. J. (2001) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00479-8 · Cited by 17
Delayed l-DOPA-induced hyperalgesia
Shimizu, T., Iwata, S., Miyata, A., Fukuda, T., & Nomoto, M. (2006) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2006.10.020 · Cited by 14
Cited by
Sex, gender, and pain: a review of recent clinical and experimental findings
Fillingim, R. B., King, C. D., Ribeiro-Dasilva, M. C., Rahim-Williams, B., & Riley, J. L. (2009) · The Journal of Pain · doi:10.1016/j.jpain.2008.12.001 · Cited by 2,766
The effect of pain on cognitive function: A review of clinical and preclinical research
Moriarty, O., McGuire, B. E., & Finn, D. P. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.01.002 · Cited by 1,122
The Role of Dopamine and Its Dysfunction as a Consequence of Oxidative Stress
Juárez Olguín, H., Calderón Guzmán, D., Hernández García, E., & Barragán Mejía, G. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/9730467 · Cited by 462
Borsook, D., Upadhyay, J., Chudler, E. H., & Becerra, L. (2010) · Molecular Pain · doi:10.1186/1744-8069-6-27 · Cited by 326
Brain glial activation in fibromyalgia – A multi-site positron emission tomography investigation
Albrecht, D. S., Forsberg, A., Sandström, A., Bergan, C., Kadetoff, D., Protsenko, E., Lampa, J., Lee, Y. C., Höglund, C. O., Catana, C., et al. (2019) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2018.09.018 · Cited by 310
“…et al., 2010; Jensen et al., 2013; Kuchinad et al., 2007; Loggia et al., 2014; Loggia et al., 2015a; Napadow and Harris, 2014; Schreiber et al., 2017; Schrepf et al., 2016; Wood, 2008), though some evidence points to peripheral alterations as well (Oaklander et al., 2013; Uceyler and Sommer, 2013).”
Metadata
- Authors
- Wood, P. B.
- Venue
- Expert Review of Neurotherapeutics
- Publisher
- Informa UK Limited
- Published
- 2008-05
- Volume
- 8
- Issue
- 5
- Pages
- 781-797
- ISSN
- 1473-7175 (ISSN-L)
- 1744-8360
- OpenAlex
- W2082215577
- Cited by
- 370
- References
- 159
- FWCI
- 10.66
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.